In contrast to the general increase of CD4+ T cells, the frequency of Foxp3 expressing cells within the CD4+ population was 4-fold lower in the vaccine-treated tumor than in the untreated tumor, while it was comparable in peripheral blood and spleen between the two groups (Figure 4C). This evidence concerns the gene FOXP3 and neoplasm.